Alexa Kimball, MD, is a renowned leader at Harvard Medical School — and her excellence has been recognized in more than one department.
Category: ROOT
Luminis Health CEO Tori Bayless doesn’t take herself too seriously
Growing up as one of four children, Tori Bayless learned the value of humor.
11 recent health system innovation moves
Health systems have been busy launching innovation initiatives and making investments in tech and spinoff companies this year.
3 healthcare-related employees named to Forbes’ top 50 workplace leaders list
Three individuals working in the field of health and mental healthcare have been named to Forbes’ inaugural list of 50 leaders who are shaping the future of the workplace.
How the Leapfrog results rank by state
Of the seven hospitals in North Dakota, one recently nabbed a “B” rating and the other six got a “C” in Leapfrog’s fall 2022 rankings.
UVM Health Network details plan to improve margins after $90M annual loss: 6 notes
The University of Vermont Health Network, a six-hospital system, posted $90 million in fiscal year 2022 losses (-3.3 percent margin), but provided details on how it plans to improve revenue, reduce expenses, and recruit and retain talent in 2023, accor…
St. Luke’s Health names Kimberly Shaw president of St. Joseph Health
Kimberly Shaw, BSN, was named president of Bryan, Texas-based St. Joseph Health, a member of Houston-based St. Luke’s Health.
UC Davis Health Eye Center 1st to try microshunt for refractory childhood glaucoma
University of California Davis Health’s Eye Center in Sacramento is the first to attempt placing microshunts in children with refractory glaucoma.
Gene-editing spinoff led by Mass General Brigham veterans
Massachusetts General Hospital in Boston has spun off a gene-editing diagnostics company aiming to partner with pharma companies to create new therapies that use the technology.
Gene-editing spinoff led by Mass General Brigham veterans
Massachusetts General Hospital in Boston has spun off a gene-editing diagnostics company aiming to partner with pharma companies to create new therapies that use the technology.
